SciELO - Scientific Electronic Library Online

vol.26 número4Autografting of peripheral-blood progenitor cells early in chronic myeloid LeukemiaIncidence evaluation of Glucose-6-Phosphate Dehydrogenase and hematological profile in Rondonia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




Links relacionados


Revista Brasileira de Hematologia e Hemoterapia

versión impresa ISSN 1516-8484versión On-line ISSN 1806-0870


MAGALHAES, Silvia Maria M.  y  LORAND-METZE, Irene. Myelodysplastic syndrome: diagnostic protocol . Rev. Bras. Hematol. Hemoter. [online]. 2004, vol.26, n.4, pp.263-267. ISSN 1516-8484.

Myelodysplastic syndromes are clonal hematological diseases with heterogeneous clinical and laboratorial presentations, which result in progressive bone marrow failure and evolve to acute leukemia. Anemia is a common symptom. In elderly patients, it is not attributed to the normal aging process and the cause is identified in most cases. The presence of cytopenias associated with bone marrow dysplastic disorders may also be due to secondary and reversible non clonal disorders. Cytogenetic abnormalities found in a proportion of patients with myelodysplastic syndromes may be helpful in the differential diagnosis and to evaluate the prognosis. Ancillary laboratory tests to show clonality are not usually available. The diagnosis of myelodysplastic syndromes is, therefore, made by exclusion, sometimes helped by the passage of time. Considering the proposed multistep myelodysplastic syndrome pathogenesis, patients at the lowest grade, presenting minimal dysplastic features may be difficult to diagnose. Vitamin B12 and/or folate deficiency, recent exposure to heavy metals and recent cytotoxic or growth factor therapy should be considered absolute exclusion factors precluding the definite diagnosis. Alcohol use, chronic inflammatory states, auto-immune disorders, chronic liver or kidney diseases, hormonal disorders and viral infections including HIV must be ruled out or interpreted with caution. Some diseases of the pluripotential stem cells must also be distinguished from myelodysplastic syndromes. Exclusion of paroxysmal nocturnal hemoglobinuria and aplastic anemia may be difficult in the less common hypocellular myelodysplastic syndromes. Dysplastic abnormalities of the bone marrow, therefore, do not in themselves establish a diagnosis of myelodysplasia and a protocol of exclusion should be carried out.

Palabras clave : Myelodysplastic syndromes; diagnosis; anemia; cytopenias.

        · resumen en Portugués     · texto en Portugués     · Portugués ( pdf epdf )


Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons